4//SEC Filing
Paykel Neela 4
Accession 0001104659-21-153333
CIK 0001833769other
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 9:42 PM ET
Size
6.9 KB
Accession
0001104659-21-153333
Insider Transaction Report
Form 4
Hyperfine, Inc.HYPR
Paykel Neela
Gen Counsel & Corp Secretary
Transactions
- Award
Stock Option (right to buy)
2021-12-22+98,250→ 98,250 totalExercise: $3.27Exp: 2031-04-27→ Class A Common Stock (98,250 underlying)
Footnotes (3)
- [F1]The shares underlying this option vested as to 25% on June 30, 2022, with the remainder of the options vesting in equal monthly installments over the following three years, subject to Ms. Paykel's continued service through the applicable vesting date.
- [F2]In connection with the closing of the transactions contemplated by the Business Combination Agreement, dated as of July 7, 2021, by and among HealthCor Catalio Acquisition Corp. ("HealthCor"), Optimus Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of HealthCor ("Merger Sub I"), Optimus Merger Sub II, Inc., a Delaware corporation and wholly owned subsidiary of HealthCor ("Merger Sub II"), Hyperfine, Inc., a Delaware corporation ("Hyperfine"), and Liminal Sciences, Inc.,
- [F3]a Delaware corporation ("Liminal"), pursuant to which Merger Sub I merged with and into Hyperfine (the "Hyperfine Merger"), with Hyperfine surviving the Hyperfine Merger as a wholly owned subsidiary of HealthCor, and Merger Sub II merged with and into Liminal (the "Liminal Merger" and, together with the Hyperfine Merger, the "Mergers"), with Liminal surviving the Liminal Merger as a wholly owned subsidiary of HealthCor (which changed its name to "Hyperfine, Inc.", the "Issuer"), the option was received in the Mergers in exchange for a stock option to acquire 300,000 shares of Hyperfine common stock for $1.07.
Documents
Issuer
Hyperfine, Inc.
CIK 0001833769
Entity typeother
Related Parties
1- filerCIK 0001894593
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 9:42 PM ET
- Size
- 6.9 KB